Skip to content
Japanese Woman in a Kimono under a parasol in the day time

Our Approach

Our Purpose

We blend heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Our Values

We are driven by Our Credo, a set of values and principles that, since 1943, has challenged and inspired us to put the needs and well-being of the people we serve first.

Our Business

We operate 90 manufacturing facilities, which are located in all major geographic regions of the world. Research facilities are located in the United States, Belgium, Brazil, China, France, Germany, India, Israel, the Netherlands, Poland, Singapore, Sweden, Switzerland and the United Kingdom, with additional R&D support in more than 30 other countries.

Our global headquarters are in New Brunswick, New Jersey, USA. Johnson & Johnson has been listed on the New York Stock Exchange since 1944 under the symbol JNJ. For changes in our business during the reporting period, please visit page 83 of our 2020 Annual Report.

venn_d_1.svg

Our Brands

Every day, we touch more than a billion lives with our products. Following are select brands that represent the diversity of the Johnson & Johnson product portfolio in our three business segments, spanning the broad continuum of healthcare.

Pharmaceutical

logo1_brands.svg

Medical Devices

Artboard – 13.png

Consumer Health

consumer_health_2.svg

2020 Financial Results

2020 Financial Results


‎Total Total
Employees 136,400
R&D investment $12.2 billion
Total sales $82.6 billion
Net earnings $14.7 billion
Market price per share, year-end close $153.09
Number of consecutive years
of dividend increases*
59
‡ See PwC's Report of Independent Accountants.
* Includes dividend declared in April 2021.

Sales by Business Segment

Sales by Business Segment

‎Category
‎Total Total
Pharmaceutical $45.6 billion
Medical Devices $23.0 billion
Consumer Health $14.1 billion

1

Our Total Tax Contribution

Our Tax Responsibility: First published in 1943, Our Credo stipulates that paying taxes is our responsibility to the communities in which we live and work. Johnson & Johnson is committed to paying our fair share of taxes. Our tax footprint evolves over time and reflects our healthcare activities and investments, including in research and development and manufacturing. What has not changed or wavered is our commitment to good corporate citizenship, which we demonstrate through sustainable values and behaviors relating to tax governance, compliance, planning, risk management, relationships with governmental authorities and transparency; these are more fully described in ourJohnson & Johnson Tax Policy.

In 2020, Johnson & Johnson contributed approximately $12 billion in taxes and fees to governments and economies around the world. This Total Tax Contribution1 is made up of two components: Total Taxes Borne by the Company and Total Taxes Collected. Taxes Borne are a direct cost to the Company, whereas Taxes Collected are collected from customers and employees on behalf of governments and ultimately remitted to them.

Our intent is to provide a comprehensive view of total taxes paid around the world. Corporate Income Tax represents payments in all markets in which we operate and is the amount reported as Income Taxes Paid in the 2020 Annual Report. Other taxes shown aggregate the Company’s data from 18 major markets representing the vast majority of our revenues. We aspire to include all markets in future years.

2020 Tax Contribution

2020 Tax Contribution

Taxes Borne
Taxes Collected
Corporate Income (billions) $4.6
Payroll and Social Insurance (billions) $1.3 $4.3
Sales/Use and Other (billions) $0.8 $1.0
Total (billions) $6.7 $5.3
Total Tax Contribution (billions)
  $12.0

Total Taxes Borne: In 2020, Johnson & Johnson bore $6.7 billion in taxes around the world. The taxes include corporate income taxes, the Company’s share of payroll and social insurance taxes, and the Company’s share of sales and other taxes. Sales taxes include sales, use, and non-recoverable value-added tax. Other taxes are primarily composed of customs and other duties such as local taxes and special fees related to the pharmaceutical industry.

Total Taxes Collected: Additionally, in 2020 Johnson & Johnson collected $5.3 billion related to the commerce the Company generates. These collections were in the form of payroll and social insurance taxes for more than 136,000 employees across the world, sales and use taxes and value-added taxes. These taxes are collected on behalf of governments, from employees, customers, and other business partners. Taxes Collected are an important part of the measure of the contribution made by Johnson & Johnson through job creation and business activities in the many countries in which we do business.

In this section

We share our progress in 2020 in the following areas:

Back to Our Approach Up next Message from Our Chairman and CEO
Back to Top
You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.
Yes, let's go